Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGB PYGL PYGM	4.24e-07	3	151	3	GO:0008184
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGB PYGL PYGM	4.19e-06	5	151	3	GO:0004645
GeneOntologyMolecularFunction	histone binding	SET NOC2L NAP1L4 CHD4 IPO9 SUPT6H TONSL ANP32A ANP32D	1.91e-04	265	151	9	GO:0042393
GeneOntologyMolecularFunction	telomeric DNA binding	XRCC5 UPF2 TINF2 ZBTB10	2.32e-04	40	151	4	GO:0042162
GeneOntologyBiologicalProcess	regulation of mRNA export from nucleus	TPR IWS1 SUPT6H	5.73e-05	11	148	3	GO:0010793
GeneOntologyBiologicalProcess	DNA-templated transcription elongation	TCEA1 ERCC3 SCAF8 INTS1 HNRNPU IWS1 SUPT6H	8.22e-05	144	148	7	GO:0006354
GeneOntologyBiologicalProcess	regulation of ribonucleoprotein complex localization	TPR IWS1 SUPT6H	9.82e-05	13	148	3	GO:2000197
GeneOntologyBiologicalProcess	glycogen catabolic process	ATG3 PYGB PYGL PYGM	1.12e-04	35	148	4	GO:0005980
GeneOntologyBiologicalProcess	ribonucleoprotein complex localization	TPR IWS1 SUPT6H	1.24e-04	14	148	3	GO:0071166
GeneOntologyBiologicalProcess	glucan catabolic process	ATG3 PYGB PYGL PYGM	1.25e-04	36	148	4	GO:0009251
GeneOntologyBiologicalProcess	positive regulation of G2/MI transition of meiotic cell cycle	CDC25A CDC25B	1.53e-04	3	148	2	GO:0110032
GeneOntologyBiologicalProcess	polysaccharide catabolic process	ATG3 PYGB PYGL PYGM	1.55e-04	38	148	4	GO:0000272
GeneOntologyCellularComponent	nuclear protein-containing complex	DCAF1 TCEA1 TPR ERCC3 POLR1A NOC2L SCAF8 CETN2 POLR2F INTS1 UBA2 XPA CHD4 RBM28 XRCC5 RFXAP HNRNPU UTP18 CHMP4A UPF2 TINF2 CLMN SUPT6H CD2BP2 ZNF335 CFDP1 TONSL HTATSF1 CPSF2	1.20e-07	1377	149	29	GO:0140513
GeneOntologyCellularComponent	nucleotide-excision repair complex	ERCC3 CETN2 XPA	9.63e-05	13	149	3	GO:0000109
Domain	PHOSPHORYLASE	PYGB PYGL PYGM	5.08e-07	3	150	3	PS00102
Domain	Glycg_phsphrylas	PYGB PYGL PYGM	5.08e-07	3	150	3	IPR011833
Domain	Glyco_trans_35	PYGB PYGL PYGM	5.08e-07	3	150	3	IPR000811
Domain	Phosphorylase	PYGB PYGL PYGM	5.08e-07	3	150	3	PF00343
Domain	EF-hand_1	CAPN12 CABP2 S100G CETN1 CETN2 FKBP9 RYR3 GUCA1A RASGRP3	3.86e-06	152	150	9	PF00036
Domain	Coatomer_WDAD	COPA COPB2	6.41e-05	2	150	2	PF04053
Domain	Coatomer_WD-assoc_reg	COPA COPB2	6.41e-05	2	150	2	IPR006692
Domain	EF_Hand_1_Ca_BS	CAPN12 CABP2 S100G CETN1 CETN2 FKBP9 GUCA1A RASGRP3	8.60e-05	175	150	8	IPR018247
Domain	ARM-type_fold	DCAF1 USP34 NOC2L INTS1 VIRMA RYR3 ITPR1 IPO9 UPF2 FHOD1 CTNND1	9.46e-05	339	150	11	IPR016024
Domain	EF_HAND_2	CAPN12 CABP2 S100G CETN1 CETN2 FKBP9 RYR3 GUCA1A RASGRP3	1.06e-04	231	150	9	PS50222
Domain	EF_hand_dom	CAPN12 CABP2 S100G CETN1 CETN2 FKBP9 RYR3 GUCA1A RASGRP3	1.10e-04	232	150	9	IPR002048
Domain	EF-hand-dom_pair	CAPN12 CACNA1F CABP2 S100G CETN1 CETN2 FKBP9 RYR3 GUCA1A RASGRP3	1.11e-04	287	150	10	IPR011992
Domain	MPI_Phosphatase	CDC25A CDC25B	1.91e-04	3	150	2	IPR000751
Domain	M-inducer_phosp	CDC25A CDC25B	1.91e-04	3	150	2	PF06617
Domain	EF_HAND_1	CAPN12 CABP2 S100G CETN1 CETN2 FKBP9 GUCA1A RASGRP3	2.47e-04	204	150	8	PS00018
Domain	-	CAPN12 CABP2 S100G CETN1 CETN2 FKBP9 RYR3 GUCA1A RASGRP3	2.65e-04	261	150	9	1.10.238.10
Domain	EFh	CABP2 S100G CETN1 CETN2 FKBP9 GUCA1A RASGRP3	2.91e-04	158	150	7	SM00054
Domain	RIH_assoc-dom	RYR3 ITPR1	9.41e-04	6	150	2	IPR013662
Domain	Ins145_P3_rec	RYR3 ITPR1	9.41e-04	6	150	2	PF08709
Domain	RIH_assoc	RYR3 ITPR1	9.41e-04	6	150	2	PF08454
Domain	RIH_dom	RYR3 ITPR1	9.41e-04	6	150	2	IPR000699
Domain	Ins145_P3_rcpt	RYR3 ITPR1	9.41e-04	6	150	2	IPR014821
Domain	Ryanodine_recept-rel	RYR3 ITPR1	9.41e-04	6	150	2	IPR015925
Domain	-	RYR3 ITPR1	9.41e-04	6	150	2	1.25.10.30
Domain	RYDR_ITPR	RYR3 ITPR1	9.41e-04	6	150	2	PF01365
Domain	MIR	RYR3 ITPR1	2.76e-03	10	150	2	PF02815
Domain	MIR_motif	RYR3 ITPR1	2.76e-03	10	150	2	IPR016093
Domain	MIR	RYR3 ITPR1	2.76e-03	10	150	2	PS50919
Domain	MIR	RYR3 ITPR1	2.76e-03	10	150	2	SM00472
Domain	Med26	TCEA1 IWS1	4.72e-03	13	150	2	PF08711
Domain	-	TCEA1 IWS1	4.72e-03	13	150	2	1.20.930.10
Domain	TFIIS_N	TCEA1 IWS1	4.72e-03	13	150	2	PS51319
Domain	EF-hand_7	CABP2 CETN1 CETN2 GUCA1A	4.89e-03	85	150	4	PF13499
Domain	TFIIS_N	TCEA1 IWS1	5.47e-03	14	150	2	IPR017923
Domain	RRM_1	SCAF8 RALYL RBM28 RBM19 ZNF638 HTATSF1	6.74e-03	208	150	6	PF00076
Domain	iLBP	RBP5 RBP1	7.14e-03	16	150	2	IPR031259
Domain	Fatty_acid-bd	RBP5 RBP1	7.14e-03	16	150	2	IPR000463
Domain	FABP	RBP5 RBP1	7.14e-03	16	150	2	PS00214
Domain	FKBP_PPIASE	FKBP9 FKBP8	7.14e-03	16	150	2	PS50059
Domain	FKBP_C	FKBP9 FKBP8	7.14e-03	16	150	2	PF00254
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION	PYGB PYGL PYGM	3.86e-05	9	111	3	M47621
Pathway	REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA	SET ANP32A ANP32D	3.86e-05	9	111	3	MM15139
Pathway	WP_MRNA_PROCESSING	DCAF1 SCAF8 RALYL RBM28 VIRMA HNRNPU EIF2D RBM19 CD2BP2 ZNF638 HTATSF1 LTV1 CPSF2	5.36e-05	451	111	13	MM15946
Pathway	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX	TCEA1 ERCC3 POLR2F IWS1 SUPT6H	9.09e-05	58	111	5	M805
Pathway	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX	TCEA1 ERCC3 POLR2F IWS1 SUPT6H	9.87e-05	59	111	5	MM14504
Pathway	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	PYGB PYGL PYGM	1.62e-04	14	111	3	M19193
Pathway	BIOCARTA_SET_PATHWAY	SET ANP32A ANP32D	1.62e-04	14	111	3	MM1403
Pathway	REACTOME_METABOLISM_OF_RNA	TPR SET ERCC3 POLR2F BMS1 PATL1 HNRNPU UTP18 UPF2 ANP32A HTATSF1 LTV1 CPSF2 ANP32D	3.13e-04	612	111	14	MM15547
Pathway	REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS	TCEA1 ERCC3 POLR2F IWS1 SUPT6H	4.40e-04	81	111	5	M865
Pathway	REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS	TCEA1 ERCC3 POLR2F IWS1 SUPT6H	4.93e-04	83	111	5	MM15314
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	ERCC3 POLR1A POLR2F CHD4	5.00e-04	47	111	4	M1095
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	ERCC3 POLR1A POLR2F CHD4	5.00e-04	47	111	4	MM15428
Pathway	REACTOME_METABOLISM_OF_RNA	TPR SET ERCC3 POLR2F BMS1 PATL1 RBM28 HNRNPU UTP18 UPF2 ANP32A HTATSF1 LTV1 CPSF2 GTPBP3	5.41e-04	724	111	15	M16843
Pathway	REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX	TCEA1 ERCC3 POLR2F XPA	6.84e-04	51	111	4	M27599
Pathway	REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX	TCEA1 ERCC3 POLR2F XPA	6.84e-04	51	111	4	MM15315
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TCEA1 TPR USP34 SET ERCC3 POLR1A COPA CETN2 COPB2 INTS1 NAP1L4 UBA2 XPA CHD4 XRCC5 VIRMA ESF1 IWS1 ATG3 SUPT6H CD2BP2 CFDP1 ANP32A HTATSF1 PYGB PYGL CTNND1 CPSF2 DNMT1	8.12e-16	1014	152	29	32416067
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DCAF1 TPR FLNB ERCC3 POLR1A COPA MYO9B NOC2L COPB2 BMS1 CHD4 RBM28 XRCC5 LUZP1 ESF1 HNRNPU EIF2D UTP18 IPO9 UPF2 MYH14 RBM19 FHOD1 ZBTB10 ZNF638 PYGB PYGL LTV1 SCRIB CTNND1 DNMT1	2.93e-14	1353	152	31	29467282
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TCEA1 TPR COPA JADE3 SCAF8 UBA2 CHD4 PATL1 VIRMA ESF1 IWS1 EIF2D UTP18 PAXBP1 ZNF335 FHOD1 ZNF638 PACS2 TAOK1 SCRIB CPSF2 ZHX1 SNX2 DNMT1	5.77e-14	774	152	24	15302935
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR USP34 FLNB POLR1A COPA NOC2L COPB2 INTS1 BMS1 CHD4 RBM28 XRCC5 VIRMA ESF1 UTP18 MYH14 SUPT6H ZNF638 PYGB PYGL DNMT1	1.24e-12	653	152	21	22586326
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	DCAF1 FLNB SET POLR1A COPA CETN1 CETN2 BMS1 CNKSR2 CHD4 IWS1 UTP18 IPO9 SUPT6H CD2BP2 PYGL SCRIB FKBP8 CTNND1 CDC25A CDC25B DNMT1	5.65e-10	1005	152	22	19615732
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	TPR NOC2L BMS1 CHD4 RBM28 XRCC5 VIRMA HNRNPU IWS1 UTP18 PAXBP1 SUPT6H RBM19 CD2BP2 ZNF638 HTATSF1 CPSF2	1.53e-09	605	152	17	28977666
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DCAF1 UNC119B NOC2L BMS1 NAP1L4 POR CC2D1A RBM28 XRCC5 ESF1 ITPR1 UTP18 PAXBP1 CD99 CLMN ANO6 SUPT6H TMX4 HTATSF1 LTV1 DNAJC1 SCRIB FKBP8 CTNND1 SNX2 DNMT1	1.57e-09	1487	152	26	33957083
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	TPR FLNB SET COPA SCAF8 COPB2 NAP1L4 CC2D1A CHD4 PATL1 XRCC5 ANKZF1 HNRNPU IWS1 PAXBP1 SUPT6H RBM19 CD2BP2 FHOD1 ANP32A ZNF638 HTATSF1 LTV1 CTNND1 DNMT1	2.74e-09	1415	152	25	28515276
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TPR FLNB SET POLR1A COPA NOC2L ZNF280C COPB2 BMS1 POR CHD4 XRCC5 ESF1 HNRNPU UTP18 PAXBP1 IPO9 MYH14 SUPT6H RBM19 ANP32A LTV1 CTNND1 SNX2 DNMT1	3.16e-09	1425	152	25	30948266
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	TCEA1 SET COPA COPB2 PATL1 RBM28 XRCC5 HNRNPU IWS1 UTP18 IPO9 ATG3 SUPT6H CFDP1 SCRIB FKBP8 DNMT1	4.77e-09	653	152	17	33742100
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	TCEA1 USP34 FLNB FAM114A1 SET COPA COPB2 FKBP9 NAP1L4 UBA2 XRCC5 UBR7 HNRNPU IWS1 IPO9 CHMP4A ATG3 MYH14 ANP32A HTATSF1 PYGB PYGL N4BP1 LTV1 SNX2	4.79e-09	1455	152	25	22863883
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TPR COPA SCAF8 COPB2 INTS1 CHD4 HNRNPU EIF2D IPO9 FHOD1 ZNF638 TAOK1 SCRIB CTNND1 CPSF2 SNX2	6.49e-09	582	152	16	20467437
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	COPA GOLM2 ZNF280C COPB2 BMS1 POR LUZP1 ESF1 ITPR1 IWS1 IPO9 CD2BP2 ZNF638 SCRIB SSH2 FKBP8 CTNND1 CPSF2 CDC25A CDC25B DNMT1	6.92e-09	1049	152	21	27880917
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ERCC3 POLR1A COPA MYO9B NOC2L COPB2 BMS1 CHD4 RBM28 XRCC5 VIRMA ESF1 HNRNPU UTP18 UPF2 CD2BP2 LTV1 DNMT1	6.95e-09	759	152	18	35915203
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ERCC3 COPA CETN2 BMS1 CC2D1A CHD4 PATL1 RBM28 XRCC5 ANKZF1 VIRMA LUZP1 MEX3C PAXBP1 IPO9 UPF2 MYH14 RBM19 CD2BP2 TAOK1 LTV1 CTNND1 CPSF2 DNMT1	7.07e-09	1371	152	24	36244648
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SET ERCC3 POLR1A BMP2K NOC2L SCAF8 CETN2 INTS1 BMS1 NAP1L4 ANKZF1 VIRMA CEP164 LUZP1 ESF1 IWS1 CRACD PAXBP1 SUPT6H RBM19 DNAJC1 FKBP8 CPSF2 ZHX1 RBFA	8.42e-09	1497	152	25	31527615
Pubmed	A Chemical Proteomics Approach to Reveal Direct Protein-Protein Interactions in Living Cells.	SET NAP1L4 UBR7 ESF1 ANP32A HTATSF1	9.22e-09	35	152	6	29104064
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	COPA JADE3 NOC2L CETN2 POLR2F INTS1 CHD4 RBM28 XRCC5 RFXAP HNRNPU IWS1 UTP18 PAXBP1 TINF2 SUPT6H CD2BP2 TONSL ZNF638 HTATSF1 DNAJC1 CPSF2 DNMT1	1.14e-08	1294	152	23	30804502
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	DCAF1 FLNB COPA NOC2L CETN2 ZNF280C BMS1 CHD4 RBM28 XRCC5 ESF1 HNRNPU UTP18 SUPT6H RBM19 CD2BP2 ANP32A ZNF638 CTNND1 DNMT1	1.38e-08	989	152	20	36424410
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	POLR1A COPA BMP2K NOC2L SCAF8 INTS1 BMS1 UBA2 CHD4 PATL1 RBM28 XRCC5 HNRNPU UTP18 PAXBP1 IPO9 UPF2 PYGL TAOK1 LTV1 CPSF2 SNX2 DNMT1	1.60e-08	1318	152	23	30463901
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	TCEA1 ERCC3 POLR1A COPA BMP2K CETN2 POLR2F COPB2 CC2D1A PATL1 LUZP1 UPF2 MYH14 RBM19 CD2BP2 NAA30 CTNND1	2.16e-08	724	152	17	36232890
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR ZNF280C NAP1L4 CC2D1A CHD4 XRCC5 ESF1 HNRNPU CCDC43 CRACD CLMN FHOD1 CFDP1 ZNF638 HTATSF1 LTV1 SCRIB CTNND1 DNMT1	2.99e-08	934	152	19	33916271
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SCAF8 PATL1 ANKZF1 ESF1 HNRNPU ITPR1 EIF2D UPF2 TONSL ZNF638 PYGB CHPF2 SCRIB FKBP8 CDC25B DNMT1	3.02e-08	650	152	16	38777146
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	TPR FLNB ERCC3 COPA NOC2L BMS1 RBM28 XRCC5 VIRMA LUZP1 ESF1 HNRNPU UTP18 UPF2 RBM19 CD2BP2 FHOD1 ZNF638 LTV1 SCRIB CTNND1 DNMT1	3.23e-08	1257	152	22	36526897
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	TPR FLNB SET POLR1A COPA POLR2F NAP1L4 UBA2 CHD4 RBM28 XRCC5 HNRNPU IPO9 UPF2 MYH14 SUPT6H LTV1 DNMT1	3.69e-08	847	152	18	35235311
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	TPR FLNB SET POLR1A NOC2L CETN2 BMS1 CHD4 RBM28 XRCC5 LUZP1 HNRNPU PAXBP1 MYH14 CD2BP2 ZBTB10 ZNF638 CTNND1	3.69e-08	847	152	18	35850772
Pubmed	Defining the membrane proteome of NK cells.	COPA MYO9B INTS1 POR CC2D1A CHD4 XRCC5 ANKZF1 LUZP1 HNRNPU ITPR1 IPO9 MYH14 ANO6 RBM19 FHOD1 PYGB CHPF2 DNAJC1 FKBP8 CPSF2	4.36e-08	1168	152	21	19946888
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TPR COPA MYO9B NOC2L RBL2 COPB2 BMS1 CHD4 ZEB2 CRACD FOXD3 CFDP1 ZBTB10 SCRIB CTNND1 CPSF2 CDC25A SNX2	4.40e-08	857	152	18	25609649
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	USP34 FLNB SET COPA NOC2L COPB2 BMS1 RBM28 XRCC5 HNRNPU IWS1 UPF2 CD2BP2 ANP32A N4BP1 LTV1 CPSF2 CDC25A DNMT1	5.49e-08	971	152	19	33306668
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP34 BMP2K BMS1 POR CC2D1A CNKSR2 CHD4 ESF1 UTP18 CD99 ANO6 RBM19 ZNF638 SCRIB FKBP8 CTNND1 DNMT1	5.99e-08	777	152	17	35844135
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ERCC3 POLR1A NOC2L CHD4 RBM28 XRCC5 ESF1 ITPR1 MYH14 SUPT6H ZBTB10 SCRIB CTNND1	7.96e-08	440	152	13	34244565
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TPR FLNB POLR1A COPA MYO9B NOC2L INTS1 CHD4 RBM28 XRCC5 HNRNPU MYH14 SUPT6H ZNF638 SCRIB FKBP8 CTNND1 CPSF2 SNX2	1.25e-07	1024	152	19	24711643
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	COPA BMP2K JADE3 NOC2L COPB2 NAP1L4 CC2D1A XPA PATL1 ANKZF1 MEX3C IWS1 UTP18 UPF2 ATG3 LTV1 SSH2 CTNND1 CDC25B	1.54e-07	1038	152	19	26673895
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	TCEA1 SET NOC2L INTS1 NAP1L4 ZEB2 LUZP1 IWS1 PAXBP1 SUPT6H ZNF638 HTATSF1 DNMT1	1.66e-07	469	152	13	27634302
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	USP34 COPA INTS1 NAP1L4 CHD4 IPO9 TINF2 CD99 DISP3 PYGB CTNND1	1.96e-07	322	152	11	26514267
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	TPR FLNB FAM114A1 NAP1L4 POR CC2D1A LUZP1 ITPR1 CCDC43 ATG3 ANO6 DNAJC1 FKBP8 SNX2	2.27e-07	568	152	14	37774976
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	TPR FLNB COPA COPB2 UBA2 CHD4 XRCC5 HNRNPU ZNF638 CPSF2 DNMT1	2.66e-07	332	152	11	32786267
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	TPR POLR1A CHD4 VIRMA HNRNPU UPF2 MYH14 ZNF638 SCRIB	2.88e-07	202	152	9	24639526
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TCEA1 TPR USP34 FLNB SET BMP2K COPB2 OBSCN XPA PATL1 RBM28 ESF1 ITPR1 PAXBP1 CLMN ZBTB10 ZNF638 TAOK1 CPSF2	2.98e-07	1084	152	19	11544199
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	USP34 FLNB SET COPA BMP2K NOC2L COPB2 BMS1 NAP1L4 CHD4 RBM28 XRCC5 HNRNPU ITPR1 IWS1 CRACD UTP18 IPO9 ANP32A DNAJC1 SCRIB FKBP8	3.36e-07	1440	152	22	30833792
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	DCAF1 SET CETN2 CHD4 SUPT6H TONSL ANP32A HTATSF1	3.44e-07	150	152	8	28242625
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	DCAF1 COPA NOC2L BMS1 CHD4 RBM28 XRCC5 UTP18 RBM19 HTATSF1 DNMT1	4.36e-07	349	152	11	25665578
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	POLR1A COPA MYO9B CHD4 RBM28 ANKZF1 LUZP1 IPO9 MYH14 PYGL TAOK1 LTV1 CTNND1 DNMT1	4.46e-07	601	152	14	33658012
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	DCAF1 USP34 SET INTS1 NAP1L4 XRCC5 ZEB2 ANP32A ZBTB10 CTNND1	5.11e-07	282	152	10	23667531
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	JADE3 ZNF280C INTS1 CHD4 XRCC5 RFXAP UBR7 ZEB2 IWS1 CFDP1 ZBTB10 ZHX1 SENP7 DNMT1	5.12e-07	608	152	14	36089195
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	FLNB NOC2L BMS1 PATL1 RBM28 XRCC5 VIRMA ESF1 MEX3C HNRNPU UTP18 SUPT6H RBM19 ANP32A ZNF638 PURG	5.57e-07	807	152	16	22681889
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	TPR SET ERCC3 COPA MYO9B COPB2 CHD4 PATL1 XRCC5 ZC3H6 LUZP1 ESF1 MEX3C HNRNPU EIF2D PAXBP1 IPO9 MYH14 ANP32A CTNND1	5.72e-07	1247	152	20	27684187
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	FLNB SET COPA RBP1 COPB2 BMS1 NAP1L4 CHD4 XRCC5 HNRNPU IWS1 UTP18 IPO9 ANO6 RBM19 CFDP1 HTATSF1 PYGB PYGL SCRIB DNMT1	5.84e-07	1367	152	21	32687490
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	DCAF1 TPR FLNB ZNF280C UBA2 CC2D1A LUZP1 HNRNPU CD2BP2 ZNF638 SNX2	5.92e-07	360	152	11	33111431
Pubmed	A bead-based approach for large-scale identification of in vitro kinase substrates.	BMS1 CHD4 IWS1 UTP18 SUPT6H CD2BP2 HTATSF1 LTV1	6.48e-07	163	152	8	22113938
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	TCEA1 TPR FLNB SET COPA CETN2 TCP11L1 COPB2 NAP1L4 UBA2 CHD4 XRCC5 LUZP1 ESF1 HNRNPU IPO9 ANP32A PYGL SNX2	7.15e-07	1149	152	19	35446349
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	FLNB SET POLR1A COPA COPB2 NAP1L4 CHD4 XRCC5 IPO9 CD2BP2 PYGB SCRIB CTNND1	7.17e-07	534	152	13	35032548
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	TPR UNC119B FLNB ERCC3 POLR1A COPA BMP2K COPB2 CHD4 RBM28 XRCC5 LUZP1 HNRNPU ITPR1 UTP18 MYH14 SCRIB	9.77e-07	949	152	17	36574265
Pubmed	Proteomic analysis of SET-binding proteins.	SET SUPT6H ANP32A PYGM ANP32D	9.85e-07	41	152	5	17309103
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FLNB COPA COPB2 FKBP9 POR CNKSR2 VIRMA LUZP1 HNRNPU PNMA8B CRACD UPF2 MYH14 CLMN PACS2 PYGB SCRIB SSH2 CTNND1 SNX2 DNAH11	1.21e-06	1431	152	21	37142655
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	DCAF1 COPA COPB2 PAXBP1 IPO9 ZNF638 SCRIB CTNND1 CPSF2 SLC2A11	1.31e-06	313	152	10	38270169
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SET ERCC3 COPA COPB2 INTS1 BMS1 NAP1L4 CHD4 XRCC5 ZC3H6 HNRNPU IWS1 PAXBP1 UPF2 SUPT6H CD2BP2 ZNF638 CPSF2	1.32e-06	1082	152	18	38697112
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SET CHD4 IWS1 PAXBP1 MYH14 SUPT6H CD2BP2 ZNF638 CPSF2	1.76e-06	251	152	9	31076518
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DCAF1 SCAF8 CNKSR2 VIRMA ZEB2 MFAP3L CRACD PACS2 CHPF2 SCRIB SENP7	1.95e-06	407	152	11	12693553
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TPR FLNB COPA CC2D1A ANKZF1 CABLES1 IWS1 UTP18 ZNF638 TAOK1 SCRIB SNX2	2.40e-06	503	152	12	16964243
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	POLR1A COPA NAP1L4 AIDA XRCC5 ITPR1 CCDC43 EIF2D UTP18 ZNF638 LTV1 CPSF2 RBFA DNMT1	2.71e-06	701	152	14	30196744
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DCAF1 FLNB COPA MYO9B BMS1 XRCC5 MYH14 DNMT1	3.23e-06	202	152	8	33005030
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	DCAF1 TPR SET COPA CETN2 TCP11L1 COPB2 NAP1L4 PATL1 HNRNPU ITPR1 PAXBP1 CD2BP2 HTATSF1 PYGM LTV1 SCRIB CDC25B	3.28e-06	1155	152	18	20360068
Pubmed	CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma.	SET RBM28 ESF1 EIF2D CFDP1 ZBTB10	3.74e-06	94	152	6	37468549
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	SET ZNF280C NAP1L4 CHD4 ESF1 HNRNPU ZNF638	4.23e-06	148	152	7	32538781
Pubmed	Human transcription factor protein interaction networks.	COPA SCAF8 COPB2 BMS1 NAP1L4 CC2D1A PATL1 RBM28 XRCC5 RFXAP ZEB2 MYH14 CD2BP2 CFDP1 ZBTB10 ZNF638 N4BP1 LTV1 CPSF2 ZHX1	4.54e-06	1429	152	20	35140242
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TPR SET ZNF280C BMS1 XRCC5 ESF1 CFDP1 ZNF638 DNMT1	4.68e-06	283	152	9	30585729
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	INTS1 VIRMA UPF2 DISP3 TAOK1 CHPF2 CPSF2	5.27e-06	153	152	7	10718198
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	TPR COPA ZNF280C COPB2 BMS1 UBA2 RBM28 XRCC5 HNRNPU UTP18 ANP32A LTV1 DNMT1	5.30e-06	641	152	13	36057605
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	TPR USP34 FLNB FAM114A1 COPA CD248 BMP2K GOLM2 COPB2 INTS1 FKBP9 POR CHD4 LUZP1 HNRNPU ITPR1 TMX4 HTATSF1 TAOK1 CPSF2	5.69e-06	1451	152	20	30550785
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	DCAF1 USP34 BMP2K NOC2L GOLM2 ZNF280C INTS1 ZNF316 POR CHD4 XRCC5 VIRMA HNRNPU UTP18 IPO9 FHOD1 TMX4 DNAJC1	5.74e-06	1203	152	18	29180619
Pubmed	Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.	SET INTS1 CHD4 XRCC5 CD2BP2 CFDP1 ZNF638	5.99e-06	156	152	7	37108203
Pubmed	Transcription-coupled nucleotide excision repair is coordinated by ubiquitin and SUMO in response to ultraviolet irradiation.	TPR UBA2 XRCC5 IWS1 SUPT6H HTATSF1	6.02e-06	102	152	6	31722399
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	MYO9B NOC2L RALYL INTS1 PATL1 HNRNPU FRY ZNF638 PACS2 TAOK1 PURG	6.52e-06	462	152	11	31138677
Pubmed	Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.	NAP1L4 UTP18 IPO9 CD99 LTV1 SCRIB CTNND1	7.07e-06	160	152	7	31678930
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	TCEA1 FLNB NOC2L COPB2 NAP1L4 UBA2 CHD4 XRCC5 HNRNPU IPO9 FHOD1 HTATSF1 PYGB FKBP8 SNX2	7.75e-06	878	152	15	37223481
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	TCEA1 TPR SET ERCC3 POLR1A INTS1 HNRNPU IPO9 SUPT6H ANP32A	9.16e-06	390	152	10	17643375
Pubmed	A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.	TPR SET COPA RALYL NAP1L4 UBA2 CHD4 XRCC5 CHMP4A ATG3 MYH14 CD2BP2 ANP32A SNX2	9.93e-06	786	152	14	29128334
Pubmed	Nuclear organization of nucleotide excision repair is mediated by RING1B dependent H2A-ubiquitylation.	COPA NOC2L CHD4 RBM28 XRCC5 HNRNPU	1.03e-05	112	152	6	28416769
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	COPA COPB2 HNRNPU PAXBP1 CD2BP2 ZNF638 HTATSF1 CTNND1	1.29e-05	244	152	8	29884807
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	FLNB FAM114A1 SET OBSCN CHD4 TTC19 UPF2 MYH14 CLMN SUPT6H PYGM	1.29e-05	497	152	11	23414517
Pubmed	The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor.	TCEA1 ERCC3 POLR2F HTATSF1	1.30e-05	33	152	4	9765201
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	TPR FLNB SET COPA INTS1 NAP1L4 HNRNPU CRACD CD2BP2 PYGL SCRIB	1.31e-05	498	152	11	36634849
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	TPR SET MYO9B POLR2F COPB2 IRX3 XRCC5 VIRMA EIF2D PAXBP1 ANP32A ZNF638 CTNND1 CPSF2 DNMT1	1.38e-05	922	152	15	27609421
Pubmed	Discovery of a Human Testis-specific Protein Complex TEX101-DPEP3 and Selection of Its Disrupting Antibodies.	FLNB COPA UBA2 XRCC5 MYH14 TMX4 PYGB PYGL	1.49e-05	249	152	8	30097533
Pubmed	Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event.	BMS1 CHD4 XRCC5 UBR7 SUPT6H TONSL DNMT1	1.63e-05	182	152	7	26527279
Pubmed	α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.	NAP1L4 CLMN SCRIB CTNND1	1.65e-05	35	152	4	37381005
Pubmed	Cdc25A and cdc25B expression in malignant lymphoma of the thyroid: correlation with histological subtypes and cell proliferation.	CDC25A CDC25B	1.90e-05	2	152	2	14767575
Pubmed	In vitro assembly and disassembly of coatomer.	COPA COPB2	1.90e-05	2	152	2	8537409
Pubmed	cDNA sequence for mouse caltractin.	CETN1 CETN2	1.90e-05	2	152	2	8218402
Pubmed	CDC25A phosphatase controls meiosis I progression in mouse oocytes.	CDC25A CDC25B	1.90e-05	2	152	2	18367163
Pubmed	Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau.	SET ANP32A	1.90e-05	2	152	2	15642345
Pubmed	Independent mechanistic inhibition of cdc25 phosphatases by a natural product caulibugulone.	CDC25A CDC25B	1.90e-05	2	152	2	17018577
Pubmed	A ubiquitous disordered protein interaction module orchestrates transcription elongation.	TCEA1 IWS1	1.90e-05	2	152	2	34822292
Pubmed	Expression of centrin isoforms in the mammalian retina.	CETN1 CETN2	1.90e-05	2	152	2	9665797
Pubmed	A sequence motif conserved in diverse nuclear proteins identifies a protein interaction domain utilised for nuclear targeting by human TFIIS.	TCEA1 IWS1	1.90e-05	2	152	2	16648364
Pubmed	Characterization of the X-linked murine centrin Cetn2 gene.	CETN1 CETN2	1.90e-05	2	152	2	11250075
Pubmed	RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B.	CDC25A CDC25B	1.90e-05	2	152	2	23708659
Pubmed	CDC25B associates with a centrin 2-containing complex and is involved in maintaining centrosome integrity.	CETN2 CDC25B	1.90e-05	2	152	2	21091437
Pubmed	Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck.	ERCC3 XPA	1.90e-05	2	152	2	29528139
Interaction	CIT interactions	TPR FLNB POLR1A COPA MYO9B NOC2L RALYL COPB2 INTS1 BMS1 POR CHD4 RBM28 XRCC5 VIRMA LUZP1 ESF1 HNRNPU IWS1 UTP18 PAXBP1 MYH14 SUPT6H RBM19 ZNF638 SCRIB SSH2 CTNND1 CPSF2 CDC25A FAM110C SNX2	1.81e-08	1450	149	32	int:CIT
Interaction	SIRT7 interactions	DCAF1 TPR USP34 FLNB POLR1A COPA NOC2L COPB2 INTS1 BMS1 CHD4 RBM28 XRCC5 VIRMA ESF1 UTP18 MYH14 SUPT6H ZNF638 PYGB PYGL DNMT1	3.00e-08	744	149	22	int:SIRT7
Interaction	NUP43 interactions	DCAF1 USP34 JADE3 NOC2L CETN2 ZNF280C ZNF316 BMS1 XPA RBM28 VIRMA UBR7 IWS1 PAXBP1 SUPT6H RBM19 CD2BP2 TONSL ZBTB10 ZHX1	3.76e-08	625	149	20	int:NUP43
Interaction	H2AC17 interactions	NOC2L CETN2 BMS1 NAP1L4 RBM28 VIRMA UTP18 IPO9 RBM19 CFDP1 TONSL LTV1	1.61e-07	232	149	12	int:H2AC17
Interaction	CDC5L interactions	TPR COPA SCAF8 COPB2 INTS1 BMS1 XPA CHD4 VIRMA HNRNPU EIF2D PAXBP1 IPO9 CD2BP2 FHOD1 ZNF638 SCRIB CTNND1 CPSF2 CDC25B SNX2 PURG	3.34e-07	855	149	22	int:CDC5L
Interaction	DDX23 interactions	SET JADE3 NOC2L BMS1 CHD4 RBM28 VIRMA CEP164 ESF1 HNRNPU IWS1 PAXBP1 SUPT6H RBM19 CD2BP2 ZNF638	5.60e-07	480	149	16	int:DDX23
Interaction	CSNK2A1 interactions	SET POLR1A RBL2 POLR2F BMS1 NAP1L4 CNKSR2 CHD4 XRCC5 ZEB2 ESF1 IWS1 EIF2D UTP18 TINF2 SUPT6H CD2BP2 CFDP1 ZBTB10 HTATSF1 LTV1 CDC25B ZHX1	5.69e-07	956	149	23	int:CSNK2A1
Interaction	ERCC6 interactions	TPR POLR1A UBA2 XPA CHD4 XRCC5 VIRMA HNRNPU IWS1 SUPT6H HTATSF1	9.01e-07	224	149	11	int:ERCC6
Interaction	ZNF330 interactions	SET NOC2L ZNF280C BMS1 NAP1L4 RBM28 VIRMA ESF1 IWS1 IPO9 SUPT6H RBM19 CFDP1 ZBTB10 DNMT1	1.15e-06	446	149	15	int:ZNF330
Interaction	DHX40 interactions	CAPN12 NOC2L BMS1 RBM28 VIRMA ESF1 ASAP2 PAXBP1 SUPT6H ZBTB10 ZNF638	2.53e-06	249	149	11	int:DHX40
Interaction	KIF20A interactions	CAPN12 FLNB COPA GDAP2 RALYL COPB2 NAP1L4 CHD4 XRCC5 VIRMA ZEB2 LUZP1 HNRNPU ITPR1 PAXBP1 CHMP4A MYH14 SUPT6H RBM19 ZNF638 SSH2 CTNND1 CPSF2	2.90e-06	1052	149	23	int:KIF20A
Interaction	CTDP1 interactions	TCEA1 SET POLR2F INTS1 VIRMA ITPR1 IWS1 CRACD ATG3 FHOD1	3.32e-06	207	149	10	int:CTDP1
Interaction	HECTD1 interactions	ERCC3 POLR1A COPA MYO9B NOC2L SCAF8 COPB2 BMS1 CHD4 RBM28 XRCC5 VIRMA ESF1 HNRNPU UTP18 PAXBP1 UPF2 CD2BP2 LTV1 SSH2 CPSF2 DNMT1	3.41e-06	984	149	22	int:HECTD1
Interaction	ANK1 interactions	OBSCN VIRMA SLC4A3 ANO6 FKBP8 RBFA	3.53e-06	56	149	6	int:ANK1
Interaction	RPL23AP32 interactions	DCAF1 NOC2L ZNF316 BMS1 NAP1L4 RBM28 RBM19	3.74e-06	87	149	7	int:RPL23AP32
Interaction	H2BC21 interactions	JADE3 NOC2L ZNF280C OBSCN NAP1L4 CHD4 XRCC5 VIRMA HNRNPU IWS1 IPO9 OTOF ATG3 SUPT6H CFDP1 ANP32A ZNF638 SENP7	4.03e-06	696	149	18	int:H2BC21
Interaction	H2AC4 interactions	POLR1A NOC2L CETN2 NAP1L4 CHD4 XRCC5 VIRMA RFXAP UBR7 IPO9 SUPT6H RBM19 CFDP1 TONSL ZNF638	5.40e-06	506	149	15	int:H2AC4
Interaction	EED interactions	DCAF1 TCEA1 TPR FLNB ERCC3 COPA BMP2K NOC2L ZNF280C COPB2 INTS1 OBSCN UBA2 CHD4 RBM28 XRCC5 VIRMA HNRNPU UTP18 IPO9 SUPT6H RBM19 ZNF638 CTNND1 CPSF2 SNX2 DNMT1	6.89e-06	1445	149	27	int:EED
Interaction	DERL1 interactions	COPA NOC2L UBA2 POR XRCC5 ITPR1 UTP18 CD99 CLMN ANO6 ANP32A TMX4 DNAJC1 FKBP8	7.06e-06	453	149	14	int:DERL1
Interaction	H2BC1 interactions	SET CETN2 NAP1L4 CHD4 HNRNPU IWS1 IPO9 CFDP1 TONSL	7.22e-06	178	149	9	int:H2BC1
Interaction	MTNR1B interactions	USP34 COPA INTS1 IPO9 TINF2 CD99 DISP3 CTNND1	7.42e-06	135	149	8	int:MTNR1B
Interaction	SUMO2 interactions	TPR FLNB SET COPA COPB2 UBA2 CHD4 XRCC5 HNRNPU ANP32A ZNF638 CTNND1 CPSF2 ZHX1 SENP7 DNMT1	8.14e-06	591	149	16	int:SUMO2
Interaction	FBXW7 interactions	POLR1A COPA MYO9B NOC2L RALYL XPA CHD4 RBM28 ANKZF1 VIRMA ZEB2 LUZP1 IPO9 MYH14 SUPT6H TONSL PYGL TAOK1 LTV1 SSH2 FKBP8 CTNND1 SENP7 DNMT1	9.67e-06	1215	149	24	int:FBXW7
Interaction	BRD1 interactions	DCAF1 USP34 JADE3 TCP11L1 ZNF316 NAP1L4 CHD4 VIRMA ZBTB10 SCRIB FKBP8 DNMT1	9.89e-06	344	149	12	int:BRD1
Interaction	H3C1 interactions	DCAF1 TPR SET ZNF280C INTS1 CHD4 RBM28 XRCC5 VIRMA RFXAP UBR7 HNRNPU MYH14 CFDP1 TONSL ANP32A ZBTB10 ZNF638 LTV1 DNMT1	1.11e-05	901	149	20	int:H3C1
Interaction	POLR1G interactions	POLR1A JADE3 NOC2L POLR2F BMS1 RBM28 ZEB2 ESF1 IWS1 UTP18 SUPT6H RBM19 CFDP1 ZBTB10	1.66e-05	489	149	14	int:POLR1G
Interaction	EFTUD2 interactions	TPR FLNB SET COPA SCAF8 COPB2 NAP1L4 CC2D1A CHD4 PATL1 XRCC5 ANKZF1 VIRMA HNRNPU IWS1 PAXBP1 RBM19 CD2BP2 FHOD1 ANP32A ZNF638 HTATSF1 LTV1 CTNND1 CPSF2 DNMT1	2.12e-05	1449	149	26	int:EFTUD2
Interaction	IFI16 interactions	TPR COPA NOC2L BMS1 OBSCN CHD4 RBM28 XRCC5 VIRMA ESF1 HNRNPU UTP18 MYH14 RBM19 ZNF638 CTNND1 DNMT1	2.21e-05	714	149	17	int:IFI16
Interaction	H2AC20 interactions	CETN2 NAP1L4 CHD4 RBM28 VIRMA IPO9 RBM19 CFDP1 TONSL ANP32A DNMT1	2.69e-05	320	149	11	int:H2AC20
Interaction	H2AC19 interactions	CETN2 VIRMA IPO9 CFDP1 TONSL	3.35e-05	50	149	5	int:H2AC19
Interaction	NAA40 interactions	TPR CETN2 ZNF280C NAP1L4 CC2D1A CHD4 XRCC5 ESF1 HNRNPU CCDC43 CRACD CLMN FHOD1 CFDP1 ZNF638 HTATSF1 LTV1 SCRIB CTNND1 DNMT1	3.57e-05	978	149	20	int:NAA40
Interaction	MTF1 interactions	COPA NOC2L CHD4 RBM28 XRCC5 VIRMA HNRNPU	3.64e-05	123	149	7	int:MTF1
Interaction	SOX2 interactions	DCAF1 USP34 SET COPA MYO9B CETN2 RBP1 INTS1 NAP1L4 CHD4 RBM28 XRCC5 ZEB2 LUZP1 MEX3C HNRNPU UTP18 CHMP4A MYH14 ANP32A ZBTB10 ZNF638 LTV1 CTNND1 ASPRV1	4.38e-05	1422	149	25	int:SOX2
Interaction	ACTB interactions	TCEA1 FLNB SET MYO9B FKBP9 CC2D1A CHD4 TSHR VIRMA LUZP1 HNRNPU CRACD IPO9 TINF2 ATG3 CLMN FHOD1 ANP32A SCRIB SSH2 CTNND1	4.86e-05	1083	149	21	int:ACTB
Interaction	NXF1 interactions	TPR UNC119B SET ERCC3 POLR1A COPA NOC2L SCAF8 RALYL BMS1 OBSCN NAP1L4 ESF1 MEX3C IWS1 PAXBP1 UPF2 SUPT6H RBM19 CD2BP2 ZNF76 SCRIB CTNND1 CDC25A	5.04e-05	1345	149	24	int:NXF1
Interaction	CEBPB interactions	TCEA1 TPR FLNB SET COPA CETN2 COPB2 BMS1 UBA2 XPA CHD4 XRCC5 ZEB2 LUZP1 HNRNPU IWS1 CD99 CD2BP2 FHOD1 ANP32A ZNF638 HTATSF1 PYGL FKBP8 DNMT1	5.56e-05	1443	149	25	int:CEBPB
Interaction	TERF2IP interactions	SET ZNF280C INTS1 UBA2 XRCC5 HNRNPU PAXBP1 TINF2 SUPT6H CFDP1 ZBTB10 ZNF638 HTATSF1 DNMT1	6.24e-05	552	149	14	int:TERF2IP
Interaction	H2BC26 interactions	RBP1 BMS1 NAP1L4 VIRMA IPO9 RBM19 CFDP1 TONSL	6.64e-05	183	149	8	int:H2BC26
Interaction	SIRT6 interactions	FLNB ERCC3 POLR1A NOC2L CHD4 RBM28 XRCC5 ESF1 ITPR1 MYH14 SUPT6H TONSL ZBTB10 SCRIB CTNND1	6.66e-05	628	149	15	int:SIRT6
Interaction	FTSJ3 interactions	DCAF1 SET NOC2L NAP1L4 CHD4 VIRMA HNRNPU UTP18 SUPT6H RBM19 LTV1 PURG	7.29e-05	422	149	12	int:FTSJ3
Interaction	PYHIN1 interactions	DCAF1 COPA NOC2L ZNF280C CHD4 XRCC5 SUPT6H HTATSF1 LTV1 CPSF2 DNMT1	7.41e-05	358	149	11	int:PYHIN1
Interaction	FBL interactions	SET POLR1A NOC2L ZNF316 BMS1 NAP1L4 CHD4 RBM28 ESF1 HNRNPU UTP18 IPO9 ATG3 RBM19 LTV1	8.08e-05	639	149	15	int:FBL
Interaction	STX4 interactions	COPA COPB2 POR CC2D1A CD99 CLMN ANO6 TMX4 DNAJC1 SCRIB FKBP8 CTNND1	8.33e-05	428	149	12	int:STX4
Interaction	DDA1 interactions	DCAF1 TCEA1 COPA NOC2L COPB2 IWS1 FRY CD2BP2 ANP32A CPSF2 CDC25B	9.46e-05	368	149	11	int:DDA1
Interaction	EP300 interactions	TCEA1 SET COPA COPB2 NAP1L4 XPA CHD4 PATL1 RBM28 XRCC5 VIRMA ZEB2 HNRNPU IWS1 UTP18 IPO9 ATG3 SUPT6H CFDP1 ZNF76 SCRIB FKBP8 CDC25A DNMT1	9.52e-05	1401	149	24	int:EP300
Interaction	SDAD1 interactions	POLR1A NOC2L CHD4 RBM28 VIRMA ESF1 ATG3 PURG	9.64e-05	193	149	8	int:SDAD1
Interaction	NR2C2 interactions	DCAF1 POLR1A COPA BMP2K NOC2L SCAF8 INTS1 BMS1 UBA2 CHD4 PATL1 RBM28 XRCC5 HNRNPU UTP18 PAXBP1 IPO9 UPF2 PYGL TAOK1 LTV1 CPSF2 SNX2 DNMT1	9.73e-05	1403	149	24	int:NR2C2
Interaction	DOT1L interactions	TPR FLNB POLR1A NOC2L CETN2 BMS1 CHD4 RBM28 XRCC5 VIRMA LUZP1 HNRNPU PAXBP1 MYH14 CD2BP2 ZNF638 CTNND1	1.01e-04	807	149	17	int:DOT1L
Interaction	PPIP5K2 interactions	COPA CETN1 COPB2 VIRMA LUZP1	1.03e-04	63	149	5	int:PPIP5K2
Interaction	RCN1 interactions	TPR COPA MYO9B COPB2 VIRMA IPO9 CHMP4A LTV1 CDC25B	1.04e-04	250	149	9	int:RCN1
Interaction	FOXL1 interactions	COPA MYO9B NOC2L ZEB2 MYH14 SCRIB CPSF2 SNX2	1.07e-04	196	149	8	int:FOXL1
Interaction	CCDC8 interactions	TPR FLNB POLR1A COPA MYO9B NOC2L INTS1 CHD4 XRCC5 HNRNPU MYH14 SCRIB FKBP8 CTNND1 SNX2	1.08e-04	656	149	15	int:CCDC8
Interaction	SNRPC interactions	OBSCN UBA2 VIRMA HNRNPU IWS1 PAXBP1 SUPT6H CD2BP2 ZNF638 HTATSF1 CPSF2 CDC25B	1.08e-04	440	149	12	int:SNRPC
Interaction	POU5F1 interactions	DCAF1 TPR USP34 FLNB COPA SCAF8 CETN2 CHD4 XRCC5 HNRNPU FOXD3 ZBTB10 TAOK1 CPSF2	1.13e-04	584	149	14	int:POU5F1
Interaction	OGFOD1 interactions	COPA UBA2 UBR7 PYGB PYGL	1.19e-04	65	149	5	int:OGFOD1
Interaction	BIRC3 interactions	TPR FLNB SET POLR1A COPA NOC2L ZNF280C COPB2 BMS1 POR CHD4 XRCC5 HNRNPU UTP18 PAXBP1 IPO9 SUPT6H RBM19 ANP32A PACS2 CTNND1 SNX2 DNMT1	1.23e-04	1334	149	23	int:BIRC3
Interaction	FGFBP1 interactions	NOC2L BMS1 RBM28 VIRMA ESF1 UTP18 RBM19 ZNF638 LTV1	1.28e-04	257	149	9	int:FGFBP1
Interaction	ZBTB44 interactions	ESF1 UTP18 MYH14 SUPT6H SCRIB	1.38e-04	67	149	5	int:ZBTB44
Interaction	H3-3A interactions	DCAF1 SET ZNF280C INTS1 CHD4 XRCC5 RFXAP UBR7 ZEB2 IWS1 CFDP1 ZBTB10 ZHX1 SNX2 SENP7 DNMT1	1.39e-04	749	149	16	int:H3-3A
Interaction	LRRC31 interactions	DCAF1 FLNB COPA MYO9B BMS1 XRCC5 MYH14 DNMT1	1.46e-04	205	149	8	int:LRRC31
Interaction	H3C2 interactions	CETN2 VIRMA UBR7 SUPT6H TONSL	1.48e-04	68	149	5	int:H3C2
Interaction	LGR4 interactions	TPR POLR1A CHD4 VIRMA HNRNPU UPF2 MYH14 ZNF638 SCRIB	1.48e-04	262	149	9	int:LGR4
Interaction	RAD18 interactions	SET COPB2 UBA2 CHD4 IWS1 PAXBP1 MYH14 SUPT6H CD2BP2 ZNF638 CTNND1 CPSF2	1.54e-04	457	149	12	int:RAD18
Interaction	H3C15 interactions	SET NAP1L4 CHD4 UBR7 ESF1 TONSL ANP32A HTATSF1	1.56e-04	207	149	8	int:H3C15
Interaction	TRIP10 interactions	POLR1A COPA COPB2 HNRNPU UPF2 TINF2	1.60e-04	109	149	6	int:TRIP10
Interaction	RPL31 interactions	SET NOC2L BMS1 NAP1L4 CC2D1A CHD4 RBM28 VIRMA ESF1 IWS1 UTP18 ATG3 SUPT6H RBM19 LTV1	1.60e-04	680	149	15	int:RPL31
Interaction	YAP1 interactions	TPR FLNB COPA COPB2 NAP1L4 UBA2 CC2D1A CNKSR2 CHD4 XRCC5 LUZP1 ESF1 HNRNPU CCDC43 MYH14 NAA30 SCRIB CTNND1 SNX2 DNMT1	1.67e-04	1095	149	20	int:YAP1
Interaction	CEP19 interactions	ZNF280C COPB2 CC2D1A IPO9 ZBTB10 LTV1 SCRIB	1.69e-04	157	149	7	int:CEP19
Interaction	HTATSF1 interactions	CHD4 VIRMA ESF1 IWS1 PAXBP1 CD2BP2 HTATSF1	1.69e-04	157	149	7	int:HTATSF1
Interaction	H3C10 interactions	VIRMA UBR7 SUPT6H TONSL	1.74e-04	38	149	4	int:H3C10
Interaction	ACE2 interactions	TCEA1 TPR FLNB COPA SCAF8 ZNF280C COPB2 BMS1 UBA2 CC2D1A RBM28 XRCC5 HNRNPU CABLES1 UTP18 CD99 ANP32A LTV1 SCRIB DNMT1	1.91e-04	1106	149	20	int:ACE2
Interaction	PAF1 interactions	TCEA1 POLR2F CHD4 XRCC5 IWS1 MYH14 HTATSF1 CPSF2	1.96e-04	214	149	8	int:PAF1
Interaction	MECP2 interactions	SET ERCC3 COPA NOC2L COPB2 INTS1 BMS1 NAP1L4 CHD4 RBM28 XRCC5 ZC3H6 ESF1 HNRNPU IWS1 PAXBP1 UPF2 SUPT6H CD2BP2 ZNF638 CPSF2 DNMT1	1.98e-04	1287	149	22	int:MECP2
Interaction	CHD4 interactions	TPR NOC2L BMS1 CHD4 RBM28 XRCC5 VIRMA HNRNPU IWS1 UTP18 PAXBP1 SUPT6H RBM19 CD2BP2 ZNF638 HTATSF1 CPSF2 DNMT1	2.00e-04	938	149	18	int:CHD4
Interaction	FRY interactions	VIRMA HNRNPU FRY	2.07e-04	16	149	3	int:FRY
Interaction	PDCD11 interactions	NOC2L BMS1 CHD4 RBM28 VIRMA CEP164 ESF1 HNRNPU SUPT6H RBM19 PURG	2.18e-04	405	149	11	int:PDCD11
Interaction	SUPT5H interactions	TCEA1 SET POLR2F INTS1 CHD4 XRCC5 ZEB2 IWS1 SUPT6H HTATSF1 CPSF2	2.32e-04	408	149	11	int:SUPT5H
Interaction	SUPT6H interactions	TCEA1 SET POLR1A POLR2F CHD4 VIRMA IWS1 SUPT6H	2.37e-04	220	149	8	int:SUPT6H
Interaction	POLR1A interactions	POLR1A COPA POLR2F COPB2 RBM28 VIRMA ATG3 SUPT6H	2.37e-04	220	149	8	int:POLR1A
Interaction	RBM19 interactions	BMS1 CHD4 RBM28 VIRMA MEX3C UTP18 RBM19 PURG	2.44e-04	221	149	8	int:RBM19
Interaction	NOP14 interactions	NAP1L4 CHD4 RBM28 VIRMA UTP18 RBM19 LTV1 PURG	2.52e-04	222	149	8	int:NOP14
Interaction	ARRDC3 interactions	COPA COPB2 PAXBP1 IPO9 ZNF638 SCRIB CTNND1 CPSF2	2.67e-04	224	149	8	int:ARRDC3
Interaction	PARP1 interactions	POLR1A NOC2L CETN1 CETN2 INTS1 BMS1 UBA2 CHD4 RBM28 XRCC5 VIRMA ESF1 ASAP2 UTP18 SUPT6H RBM19 FHOD1 ZBTB10 SCRIB CPSF2 SNX2 DNMT1	2.71e-04	1316	149	22	int:PARP1
Interaction	SRRM1 interactions	CETN2 CHD4 VIRMA HNRNPU UPF2 CD2BP2 ZNF638 HTATSF1 LTV1 PURG	2.71e-04	348	149	10	int:SRRM1
Interaction	H3C12 interactions	UBR7 IWS1 SUPT6H TONSL	2.83e-04	43	149	4	int:H3C12
Interaction	H3C3 interactions	JADE3 ZNF280C CHD4 XRCC5 UBR7 ZEB2 IWS1 SUPT6H TONSL ZBTB10 SENP7 DNMT1	3.20e-04	495	149	12	int:H3C3
Interaction	DCTN1 interactions	TPR RBL2 NAP1L4 CC2D1A CHD4 VIRMA LUZP1 HNRNPU IPO9 CFDP1 LTV1 SNX2	3.32e-04	497	149	12	int:DCTN1
Interaction	CTR9 interactions	TCEA1 CETN2 POLR2F CHD4 IWS1 MYH14 SUPT6H CPSF2	3.48e-04	233	149	8	int:CTR9
Interaction	H2AC8 interactions	CETN2 NAP1L4 VIRMA IPO9 CFDP1 TONSL LTV1	3.52e-04	177	149	7	int:H2AC8
Interaction	H2BC8 interactions	JADE3 CETN2 ZNF280C INTS1 BMS1 CHD4 XRCC5 VIRMA ESF1 IWS1 IPO9 CFDP1 DNMT1	3.58e-04	576	149	13	int:H2BC8
Interaction	ATL3 interactions	TPR COPA COPB2 POR VIRMA SUPT6H HTATSF1	3.77e-04	179	149	7	int:ATL3
Interaction	HDAC4 interactions	TPR COPA SCAF8 CETN2 VIRMA RFXAP ZEB2 HNRNPU ITPR1 IWS1 FRY CLMN ZNF638 CDC25B DNMT1	4.18e-04	744	149	15	int:HDAC4
Interaction	H2AZ1 interactions	SET JADE3 ZNF280C NAP1L4 CHD4 XRCC5 IPO9 UPF2 CFDP1 PYGL	4.49e-04	371	149	10	int:H2AZ1
Interaction	AATF interactions	POLR1A NOC2L RBL2 RBM28 CEP164 ESF1 HNRNPU UTP18 ATG3 RBM19	4.98e-04	376	149	10	int:AATF
Interaction	MNDA interactions	COPA NOC2L RBL2 BMS1 RBM28 UTP18 RBM19	5.06e-04	188	149	7	int:MNDA
Interaction	H3-4 interactions	DCAF1 SET JADE3 NOC2L RBP5 NAP1L4 CHD4 HNRNPU TONSL ANP32A DNMT1	5.12e-04	448	149	11	int:H3-4
Interaction	USP36 interactions	POLR1A NOC2L BMS1 CHD4 RBM28 XRCC5 VIRMA CEP164 ESF1 HNRNPU UTP18 RBM19 ZNF638	5.17e-04	599	149	13	int:USP36
Interaction	H2AB3 interactions	CETN2 BMS1 RBM28 RBM19 ZNF335 ZNF638	5.27e-04	136	149	6	int:H2AB3
Interaction	DNAJB6 interactions	TCEA1 NOC2L BMS1 CEP164 HNRNPU UTP18 SUPT6H FKBP8 SNX2 DNMT1	5.30e-04	379	149	10	int:DNAJB6
Interaction	KRR1 interactions	SET RALYL BMS1 CHD4 RBM28 HNRNPU RBM19 ZNF335 LTV1 PURG	5.30e-04	379	149	10	int:KRR1
Cytoband	7p11.1	FKBP9 FKBP9P1	1.09e-05	2	152	2	7p11.1
GeneFamily	Glycogen phosphorylases	PYGB PYGL PYGM	1.64e-07	3	100	3	437
GeneFamily	EF-hand domain containing	CAPN12 CABP2 S100G CETN1 CETN2 FKBP9 RYR3 GUCA1A RASGRP3	3.49e-06	219	100	9	863
GeneFamily	Class III Cys-based CDC25 phosphatases	CDC25A CDC25B	9.05e-05	3	100	2	713
GeneFamily	ANP32 acidic nuclear phosphoproteins	ANP32A ANP32D	3.00e-04	5	100	2	27
GeneFamily	WD repeat domain containing\|Xeroderma pigmentosum complementation groups\|Nucleotide excision repair	ERCC3 XPA	8.30e-04	8	100	2	1125
GeneFamily	RNA binding motif containing	SCAF8 RALYL RBM28 RBM19 ZNF638 HTATSF1	1.18e-03	213	100	6	725
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB2 ZHX1	3.03e-03	15	100	2	529
GeneFamily	Fatty acid binding protein family	RBP5 RBP1	3.46e-03	16	100	2	550
GeneFamily	FKBP prolyl isomerases	FKBP9 FKBP8	4.37e-03	18	100	2	910
Coexpression	GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP	TPR FLNB FAM114A1 POLR1A RALYL VIRMA CD99 ANP32A CPSF2 CDC25A	2.43e-07	197	152	10	M9725
Coexpression	HOUNKPE_HOUSEKEEPING_GENES	COPA COPB2 NAP1L4 UBA2 AIDA PATL1 HNRNPU IWS1 EIF2D UTP18 IPO9 ATG3 SUPT6H CD2BP2 CFDP1 ANP32A TMX4 PCSK7 HTATSF1 LTV1 DNAJC1 FKBP8 ANP32D	2.45e-07	1158	152	23	MM1338
Coexpression	HOUNKPE_HOUSEKEEPING_GENES	COPA COPB2 NAP1L4 UBA2 AIDA PATL1 HNRNPU IWS1 EIF2D UTP18 IPO9 ATG3 SUPT6H CD2BP2 CFDP1 ANP32A TMX4 PCSK7 HTATSF1 LTV1 DNAJC1 FKBP8	6.34e-07	1129	152	22	M42508
Coexpression	GSE25677_MPL_VS_R848_STIM_BCELL_DN	FLNB AIDA FRY RASGRP3 SSH2 CDC25B SNX2 DNMT1	1.11e-05	181	152	8	M8187
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TPR USP34 SET MYO9B SCAF8 RBL2 NAP1L4 UBA2 AIDA XRCC5 ZC3H6 ZEB2 LUZP1 HNRNPU ITPR1 TINF2 FHOD1 ZNF638 TAOK1 N4BP1 SSH2 SENP7 DNMT1	1.71e-05	1492	152	23	M40023
Coexpression	GSE20727_CTRL_VS_H2O2_TREATED_DC_DN	FLNB CHD4 AIDA ZC3H6 ZBTB10 PCSK7 PYGM SSH2	1.98e-05	196	152	8	M9243
Coexpression	GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP	ERCC3 CETN2 ZNF280C UBA2 RBM28 HTATSF1 CPSF2 SNX2	2.21e-05	199	152	8	M3328
Coexpression	GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN	BMP2K XPA FRY PACS2 SSH2 SNX2 RBFA DNMT1	2.29e-05	200	152	8	M8656
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP	TCEA1 POR RBM28 ASAP2 ATG3 CHPF2 SCRIB FKBP8	2.29e-05	200	152	8	M9831
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	DCAF1 TCEA1 TPR CACNA1F SET CABP2 JADE3 NAP1L4 POR IRX3 LUZP1 ESF1 HNRNPU IWS1 PAXBP1 IPO9 MYH14 TONSL ANP32A NAA30 N4BP1 SENP7	1.60e-06	989	149	22	Facebase_RNAseq_e10.5_Maxillary Arch_1000
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	RBM28 CEP164 ESF1 UPF2 CFDP1 ZNF638 CDC25B DNMT1	4.01e-07	197	152	8	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	BMP2K MYO9B CHD4 ZEB2 ITPR1 RASGRP3 SNX2	1.50e-06	163	152	7	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F OBSCN CNKSR2 FREM1 RYR3 DISP3 DNAH11	3.35e-06	184	152	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F OBSCN CNKSR2 FREM1 RYR3 DISP3 DNAH11	3.35e-06	184	152	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F OBSCN CNKSR2 FREM1 RYR3 DISP3 DNAH11	3.35e-06	184	152	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TPR USP34 JADE3 LUZP1 IWS1 CRACD UPF2	3.60e-06	186	152	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	ILEUM-non-inflamed-(5)_Plasma-(5)_IgM_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FKBP9 CHD4 UPF2 RASGRP3 ZFTA	4.18e-06	70	152	5	aa63c1b77a9fb15e75835cb3781f2d890f3fe328
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K HNRNPU RASGRP3 ANP32A TMX4 TAOK1 SSH2	4.59e-06	193	152	7	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K HNRNPU RASGRP3 ANP32A TMX4 TAOK1 SSH2	4.59e-06	193	152	7	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K HNRNPU RASGRP3 ANP32A TMX4 TAOK1 SSH2	4.59e-06	193	152	7	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K HNRNPU RASGRP3 ANP32A TMX4 TAOK1 SSH2	4.59e-06	193	152	7	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCP11L1 EIF2D OTOF CARF SCRIB ZHX1	2.89e-05	173	152	6	12f779b8dce79431b2d1002ba524dd3f9566aeb0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	BMP2K CHD4 ZEB2 ITPR1 RASGRP3 SNX2	2.89e-05	173	152	6	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CNKSR2 CABLES1 CRACD FOXD3 ZNF76 DNAJC1	3.61e-05	180	152	6	c72f15763ba707189e29c85db533557f01c7fdb1
ToppCell	IIH-Treg-proli_CD4\|IIH / Condition, Cell_class and T cell subcluster	NOC2L ZNF335 CARF SSH2 CTNND1 SLC2A11	3.84e-05	182	152	6	5c7d02da9ca2bca49db9832704b6894dfaa08a71
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CABLES1 RASGRP3 ANP32A TMX4 SSH2	4.73e-05	189	152	6	6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CABLES1 RASGRP3 ANP32A TMX4 SSH2	4.73e-05	189	152	6	3ae479ec7e00c57127cbe51a398329b10ca9848c
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CABLES1 RASGRP3 ANP32A TMX4 SSH2	4.73e-05	189	152	6	875df61ee48baa5142ba4d2427bdec1c53e5a828
ToppCell	facs-Brain_Myeloid-Striatum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CABLES1 RASGRP3 ANP32A TMX4 SSH2	4.73e-05	189	152	6	97ef5215d841ff366a3e3682cd9bd04100cbfde0
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCEA1 TPR USP34 SET BMP2K MFAP3L	5.02e-05	191	152	6	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	facs-Pancreas-Endocrine-3m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JADE3 HNRNPU ITPR1 PNMA8B ANP32A TMX4	5.02e-05	191	152	6	b3de0393d6510543533cd851e47a0f95739a0e4e
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	RSPH4A LRRC10B IRX3 RYR3 MYH14 DNAH11	5.02e-05	191	152	6	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPR NAP1L4 TTC19 PCSK7 CDC25B PURG	5.02e-05	191	152	6	c5e22df4a8741b8096cdd1618271fd48d6265846
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCEA1 TPR USP34 SET BMP2K MFAP3L	5.02e-05	191	152	6	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	RSPH4A LRRC10B IRX3 RYR3 MYH14 DNAH11	5.02e-05	191	152	6	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCEA1 TPR USP34 SET BMP2K MFAP3L	5.02e-05	191	152	6	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RBP1 FKBP9 ZEB2 FREM1 FHOD1 PYGM	5.17e-05	192	152	6	2802fae55683345ff94a1ecf73b6fbee4f17481e
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	POR CFDP1 DNAJC1	5.55e-05	22	152	3	e345c8c639ca1935b2e2c32533cc8e30819acfeb
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CETN2 RBP1 POLR2F IRX3 RBM28 RYR3	5.63e-05	195	152	6	32ec72103faccc9e37c0ecedff1998e7df6a19f6
ToppCell	droplet-Marrow-BM-1m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SET NOC2L UBA2 RFXAP CPSF2 SNX2	5.63e-05	195	152	6	637b06ef3967b03f7165d102d316e8b7161a817d
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RBP1 FKBP9 ZEB2 FREM1 FHOD1 PYGM	5.63e-05	195	152	6	b072fdc2131173f562e55dd78226eaf2c57d3690
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COPA COPB2 FKBP9 HNRNPU CSRNP1 TAOK1	5.96e-05	197	152	6	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	facs-Trachea-nan-3m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA COPB2 FKBP9 HNRNPU CSRNP1 TAOK1	5.96e-05	197	152	6	0353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPR RBL2 TTC19 HNRNPU ZNF638 PCSK7	6.13e-05	198	152	6	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	POLR2F RALYL RFTN2 FOXD3 PYGB DNAJC1	6.13e-05	198	152	6	5b9a7b9f53a3d9cf8d6e6a7c1c94514b22cf9fa8
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RBP1 RALYL RFTN2 ZEB2 FOXD3 DNAJC1	6.30e-05	199	152	6	ce699726ac4825c65bf934cb9a76202ad7340596
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-NK_CD56bright\|Influenza_Severe / Disease, condition lineage and cell class	CAPN12 PSD ZNF280C CABLES1 CARF PYGM	6.30e-05	199	152	6	784e7e7ede2baa28ede600834813e6de2240bfdf
ToppCell	LPS-IL1RA+antiTNF-Unknown-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERCC3 VSIG10 RYR3 RASGRP3 PYGM	9.02e-05	132	152	5	46c80eab16a70da9f363a9fbdf50bccab0b287d7
ToppCell	LPS-IL1RA+antiTNF-Unknown\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERCC3 VSIG10 RYR3 RASGRP3 PYGM	9.02e-05	132	152	5	a022c3c41654166cb106f27dc54fa88e8c40f898
Computational	Neighborhood of RAD21	TCEA1 TPR SET HNRNPU HTATSF1	1.87e-05	37	97	5	GCM_RAD21
Computational	Neighborhood of RAB11A	TPR XPA CFDP1 HTATSF1 SCRIB	1.99e-04	60	97	5	MORF_RAB11A
Drug	Gvapspat amide	RYR3 ITPR1 PYGB PYGL PYGM	3.42e-08	15	151	5	CID000125015
Drug	3,5-dimethylphenyl isocyanate	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000521488
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000147839
Drug	NSC758405	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000151920
Drug	pyridoxal phosphoglucose	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000196007
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000093111
Drug	adenosine-5'-chloromethylphosphonate	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000191554
Drug	hydan	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000008360
Drug	EHMF	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000033931
Drug	pyridoxal 5'-methylenephosphonate	PYGB PYGL PYGM	2.86e-07	3	151	3	CID003082249
Drug	Plp 5'-mpa	PYGB PYGL PYGM	2.86e-07	3	151	3	CID003082151
Drug	glucose-1,2-cyclic phosphate	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000191723
Drug	3'-FFdUrd	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000072260
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000119518
Drug	AC1L8XK3	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000446801
Drug	riboflavin tetraacetate	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000094186
Drug	2,5-dimethyl-3-furanone	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000085730
Drug	3,5-dinitrophenol	PYGB PYGL PYGM	2.86e-07	3	151	3	CID000011459
Drug	AC1L8YNX	PYGB PYGL PYGM CDC25A CDC25B	3.67e-07	23	151	5	CID000410238
Drug	galocitabine	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000065950
Drug	5-deoxyribose-1-phosphate	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000135786
Drug	ingliforib	PYGB PYGL PYGM	1.14e-06	4	151	3	CID006451325
Drug	uric acid riboside	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000164933
Drug	pseudo-dl-glucose	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000125259
Drug	pyridoxal diphosphate	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000125696
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000189134
Drug	AC1LAMW2	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000491364
Drug	FdUrd-C8	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000094262
Drug	Mem-CC	PYGB PYGL PYGM	1.14e-06	4	151	3	CID003081269
Drug	BCIp4A	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000192417
Drug	3'-chloromethotrexate	PYGB PYGL PYGM	1.14e-06	4	151	3	CID000097703
Drug	phenylselenenyl chloride	XPA PYGB PYGL PYGM	1.27e-06	13	151	4	CID000021928
Drug	sotolon	RBP1 PYGB PYGL PYGM	2.40e-06	15	151	4	CID000062835
Drug	heptulose-2-P	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000124823
Drug	6-FPLP	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000146246
Drug	gluconohydroximo-1,5-lactone	PYGB PYGL PYGM	2.83e-06	5	151	3	CID009576855
Drug	DHPBU	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000125914
Drug	5'-isobutylthioinosine	PYGB PYGL PYGM	2.83e-06	5	151	3	CID003080910
Drug	indirubin-5-sulphonate	PYGB PYGL PYGM	2.83e-06	5	151	3	CID005288641
Drug	AC1LCUXJ	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000656425
Drug	6-amino-5-bromouracil	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000080578
Drug	etafenone	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000003275
Drug	ddEtUrd	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000451452
Drug	5-trifluoromethyl-2'-deoxycytidine	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000125618
Drug	m-anisidine	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000010824
Drug	2-hydroxypropylphosphonate	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000441028
Drug	6-FDPL	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000129578
Drug	3'-O-methylpyridoxal 5'-phosphate	PYGB PYGL PYGM	2.83e-06	5	151	3	CID003082179
Drug	GlcMan	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000152120
Drug	U66985	PYGB PYGL PYGM	2.83e-06	5	151	3	CID000127224
Drug	AC1O3M08	PYGB PYGL PYGM	2.83e-06	5	151	3	CID006331955
Drug	diazinon	SET CETN2 RFXAP PYGB PYGL PYGM DNAH11	4.10e-06	98	151	7	CID000003017
Drug	CV-araU	PYGB PYGL PYGM	5.64e-06	6	151	3	CID006441877
Drug	2-thiothymidine	PYGB PYGL PYGM	5.64e-06	6	151	3	CID003005944
Drug	Carbocyclic Bvdc	PYGB PYGL PYGM	5.64e-06	6	151	3	CID006438602
Drug	2,2-dimethyl-3-hydroxybutyric acid	PYGB PYGL PYGM	5.64e-06	6	151	3	CID000152984
Drug	EdUMP	PYGB PYGL PYGM	5.64e-06	6	151	3	CID003085112
Drug	5'-deoxy-5'-chloroformycin	PYGB PYGL PYGM	5.64e-06	6	151	3	CID000126430
Drug	5-n-propylthioadenosine	PYGB PYGL PYGM	5.64e-06	6	151	3	CID000656428
Drug	AzddCyd	PYGB PYGL PYGM	5.64e-06	6	151	3	CID000451374
Drug	5-Ffdru	PYGB PYGL PYGM	5.64e-06	6	151	3	CID000065561
Drug	Carbocyclic Ivdu	PYGB PYGL PYGM	5.64e-06	6	151	3	CID006439191
Drug	DNPP	PYGB PYGL PYGM	5.64e-06	6	151	3	CID000067056
Drug	5-chloro-indole-2-carboxylic acid	PYGB PYGL PYGM	5.64e-06	6	151	3	CID000082693
Drug	NSC-97433	PYGB PYGL PYGM	5.64e-06	6	151	3	CID000001803
Drug	AR-L57	PYGB PYGL PYGM	5.64e-06	6	151	3	CID000156890
Drug	alpha-(fluoromethyl)dehydroornithine	PYGB PYGL PYGM	9.82e-06	7	151	3	CID006439607
Drug	6-fluoropyridoxal	PYGB PYGL PYGM	9.82e-06	7	151	3	CID003080803
Drug	AC1L3372	PYGB PYGL PYGM	9.82e-06	7	151	3	CID000108025
Drug	1 Gpt	PYGB PYGL PYGM	9.82e-06	7	151	3	CID000101247
Drug	formycins	PYGB PYGL PYGM	9.82e-06	7	151	3	CID000512867
Drug	5'-methylthioinosine	PYGB PYGL PYGM	9.82e-06	7	151	3	CID000161214
Drug	hydantocidin	PYGB PYGL PYGM	9.82e-06	7	151	3	CID000125429
Drug	2',3'-dideoxy-3'-fluorocytidine	PYGB PYGL PYGM	9.82e-06	7	151	3	CID000356019
Drug	heptenitol	PYGB PYGL PYGM	9.82e-06	7	151	3	CID000188267
Drug	Promonta	PYGB PYGL PYGM	9.82e-06	7	151	3	CID000108494
Drug	AC1NBU2S	CACNA1F RYR3 ITPR1 TONSL PYGB PYGL PYGM	1.32e-05	117	151	7	CID004473765
Drug	flavopiridol	RBL2 POLR2F POR XRCC5 SUPT6H HTATSF1 PYGB PYGL PYGM	1.45e-05	216	151	9	CID005287969
Drug	6-methylpurine	PYGB PYGL PYGM	1.56e-05	8	151	3	CID005287547
Drug	Etafenone [inn]	PYGB PYGL PYGM	1.56e-05	8	151	3	CID000066659
Drug	AC1NUVX5	PYGB PYGL PYGM	1.56e-05	8	151	3	CID005461894
Drug	amorphin	PYGB PYGL PYGM	1.56e-05	8	151	3	CID000122792
Drug	nitrosyliodide	POLR1A POLR2F PYGB PYGL CDC25A	1.63e-05	48	151	5	CID000143560
Drug	alpha-maltosyl fluoride	PYGB PYGL PYGM	2.33e-05	9	151	3	CID000194237
Drug	6-benzyl-2-thiouracil	PYGB PYGL PYGM	2.33e-05	9	151	3	CID000685814
Drug	5'-methylthiotubercidin	PYGB PYGL PYGM	2.33e-05	9	151	3	CID000188350
Drug	5-Iodoribose 1-phosphate	PYGB PYGL PYGM	2.33e-05	9	151	3	CID003035973
Drug	5'-iodo-5'-deoxyadenosine	PYGB PYGL PYGM	2.33e-05	9	151	3	CID000107502
Drug	AC1Q6S45	RBL2 PYGB PYGL PYGM	2.90e-05	27	151	4	CID000000508
Drug	8-azidoadenosine 5'-monophosphate	PYGB PYGL PYGM	3.32e-05	10	151	3	CID000124726
Drug	6-methyluridine	PYGB PYGL PYGM	3.32e-05	10	151	3	CID000092887
Drug	UDP-pyridoxal	PYGB PYGL PYGM	3.32e-05	10	151	3	CID000126789
Drug	2,6-dihydroxypyridine	PYGB PYGL PYGM	3.32e-05	10	151	3	CID000069371
Drug	Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	TPR USP34 SET MYO9B HNRNPU IPO9 RBM19 HTATSF1	4.08e-05	190	151	8	2299_DN
Drug	5-(2-chloroethyl)uracil	PYGB PYGL	4.37e-05	2	151	2	CID010442204
Drug	6878P	PYGB PYGL	4.37e-05	2	151	2	CID002725013
Drug	AC1LBRFU	PYGB PYGL	4.37e-05	2	151	2	CID000562981
Drug	1-N-Acetyl-Beta-D-Glucosamine	PYGL PYGM	4.37e-05	2	151	2	DB02320
Disease	vulva squamous cell carcinoma (is_marker_for)	CDC25A CDC25B	7.17e-05	3	145	2	DOID:2101 (is_marker_for)
Disease	xeroderma pigmentosum (is_implicated_in)	ERCC3 XPA	3.55e-04	6	145	2	DOID:0050427 (is_implicated_in)
Disease	Intellectual Disability	SET XPA RBM28 UBR7 HNRNPU FRY ZNF335 PACS2 TAOK1	3.83e-04	447	145	9	C3714756
Disease	body weight	ARSJ POLR1A ZNF280C RALYL CNKSR2 VIRMA TTC19 MEX3C ITPR1 UTP18 IPO9 RBM19 ZNF638 SCRIB CPSF2 PURG	4.91e-04	1261	145	16	EFO_0004338
Disease	Cerebellar Diseases	ZEB2 TINF2	4.96e-04	7	145	2	C0007760
Disease	Xeroderma pigmentosum	ERCC3 XPA	8.44e-04	9	145	2	cv:C0043346
Disease	rectum cancer (is_implicated_in)	CHD4 XRCC5	8.44e-04	9	145	2	DOID:1993 (is_implicated_in)
Disease	Basal cell carcinoma	ERCC3 XPA	1.28e-03	11	145	2	C0007117
Disease	AL amyloidosis	CHPF2 DNAH11	1.53e-03	12	145	2	MONDO_0019438
Disease	cardiovascular disease	USP34 POLR1A MYO9B FREM1 MEX3C CFDP1 CDC25A DNMT1	1.96e-03	457	145	8	EFO_0000319
Disease	proprotein convertase subtilisin/kexin type 7 measurement	CEP164 PCSK7	3.11e-03	17	145	2	EFO_0008270
Disease	Global developmental delay	INTS1 ZNF335 PACS2 TAOK1	4.27e-03	133	145	4	C0557874

Protein segments in the cluster

Peptide	Gene	Start	Entry
EEDGEVKDYGEEDLQ	BEND5	101	Q7L4P6
IQEEGGAGVDEEEEE	SLC4A3	126	P48751
GFGDDVDEDELLEEL	CHMP4A	151	Q9BY43
EEQEEEEATGETFLG	DISP3	16	Q9P2K9
EGEEENGEVHQARED	EIF2D	221	P41214
VILEEGELKDDGEDS	CPSF2	646	Q9P2I0
ARAGVQADEDEDGDE	DNMT1	266	P26358
TEDGIEDAFEVLGEI	COPB2	506	P35606
SQDLGDELLDDGEDE	CD248	361	Q9HCU0
IDFGEDDNLEEGVLE	GTPBP3	206	Q969Y2
EAEAGAEELEQAAEG	CCDC96	121	Q2M329
GLEAVGAVELEEEEE	DNAH11	26	Q96DT5
EENLEFEEDEEEGGA	AIDA	126	Q96BJ3
EGKLEGLTDEFEELE	ANP32A	31	P39687
DDFDLGDAVVDGEND	CD99	51	P14209
IDEADRDGDGEVSEQ	CETN2	146	P41208
EEEQDDEEVLQGEQG	BMP2K	756	Q9NSY1
NEEEDDDTLEELGGL	BMS1	701	Q14692
DAEGVAAEEEQEGDS	DNAJC1	416	Q96KC8
SDELEAIIEEDDGDG	ATG3	91	Q9NT62
LSGEEVEDDLDLVGA	RBFA	296	Q8N0V3
EDFDEDGGHELFLQI	RALYL	276	Q86SE5
EEEGAGEDLEEEASL	RBM19	181	Q9Y4C8
SEEEELGELLQQFGE	RBM28	346	Q9NW13
LRELDDGQFDQEDGV	RFTN2	481	Q52LD8
NLIADIFGESGDEEE	IWS1	471	Q96ST2
GNLDERIFLGEDAEE	RBL2	346	Q08999
EDDDDGDIVLENLGQ	ANO6	16	Q4KMQ2
EEEEEGAGGVELLQE	CACNA1F	821	O60840
GAYILGILQEEEEEE	CCDC43	41	Q96MW1
DNQEEEDEGLGVDLS	GDAP2	266	Q9NXN4
TGEAIEDDDNFEEGE	NAP1L4	336	Q99733
PLDEDEDAFQGLGEE	PATL1	11	Q86TB9
EDAFQGLGEEDEEID	PATL1	16	Q86TB9
GLGEEDEEIDQFNDD	PATL1	21	Q86TB9
LANLLEEGEDGEDED	DCAF1	1461	Q9Y4B6
DDQEGGQFEVKDVEE	MFAP3L	331	O75121
DDDEIGALDNAELEG	LTV1	271	Q96GA3
FELGLGDDDGNLEED	POR	201	P16435
IEAAELEGNDDRIEG	INTS1	126	Q8N201
EVEFEDGENGEDGAA	ITPR1	2141	Q14643
EEEEEEGSVGNLDNL	CSRNP1	406	Q96S65
EEEEEGALLAQAGEK	ARSJ	51	Q5FYB0
SEGDVIIVDGEEDQE	ASAP2	966	O43150
DELVEVGDVEDTGNL	CARF	646	Q8N187
EEELQGDDGVNVEED	ESF1	551	Q9H501
DGTEAEADVIENEDG	FLNB	1656	O75369
RQEEEAGALEAGEEA	MYH14	1396	Q7Z406
LEGDGEEETLEQQAD	PCSK7	61	Q16549
EIDKDGNGEVLLEEF	FKBP9P1	71	Q75LS8
DGLEEDDEVFEVILN	FREM1	1816	Q5H8C1
ENGDDQGFQEGEDEL	HNRNPU	131	Q00839
QGFQEGEDELGDEEE	HNRNPU	136	Q00839
AEGDTEEDDGFVDIL	CDC25B	261	P30305
FEDEEEEDLLIGGAG	LRRC10B	256	A6NIK2
IDLGEDDMEFGEDDI	GPR101	346	Q96P66
IAEEIGIEGSDDDAL	PAXBP1	286	Q9Y5B6
AVQGQDLDEDDFDVG	PACS2	216	Q86VP3
VLEEASEEEDGAEEG	NOC2L	116	Q9Y3T9
EENGLEKDLDEEGSE	HTATSF1	566	O43719
LENVEALEGGEALFE	OBSCN	4346	Q5VST9
DKDGNGEVLLEEFSE	FKBP9	501	O95302
VTFQGVGDEEDEDEI	CD2BP2	6	O95400
GLEQLFQELAGEEEE	CAPN12	551	Q6ZSI9
GGLSLEEEEEEDANS	CFDP1	66	Q9UEE9
LEDFEVLDGVEDAEG	FKBP8	21	Q14318
GELEELEEERAACQG	SLC2A11	241	Q9BYW1
LEVEDEEGSLFVGVD	CTRC	91	Q99895
GAAGQEELEEDDAFI	CABLES1	201	Q8TDN4
EGEDGFQVELELVEL	ANKZF1	406	Q9H8Y5
GEDAELQLDEDGFVE	COPA	846	P53621
AEEEDLGEEEEEGQA	CRACD	396	Q6ZU35
DEELEAEFLALVGGQ	CC2D1A	41	Q6P1N0
KELENGEVEGEDAFL	LUZP1	351	Q86V48
GEQDEEGADEAAEAA	GUCA1A	186	P43080
EEEEEEEDGLAGQLL	IPO9	956	Q96P70
DLDAEEEVVAGEFGS	ERCC3	721	P19447
FDFLDVELEDGEGES	FRY	2461	Q5TBA9
IGDLDFSDLGEDEDQ	FHOD1	541	Q9Y613
EEFITDEQKDEEGDG	FAM9C	126	Q8IZT9
DNSEGEEILEEVGGD	CHD4	426	Q14839
EEILEEVGGDLEEED	CHD4	431	Q14839
GDDEGLQEEELIEQV	FAM110C	266	Q1W6H9
DEGQDGVEEEVFEQE	SCAF8	376	Q9UPN6
VDLNGDGLVDFEEFV	CABP2	201	Q9NPB3
EELDVLVLDDEGGQV	CTNND1	946	O60716
LKFQAVGEEDEEDEE	FAM167B	6	Q9BTA0
AIETEEGLGIEYDED	JADE3	186	Q92613
EDVDIDVVGEGDDGL	FOXD3	21	Q9UJU5
LSDEDDGFVDLLDGE	CDC25A	211	P30304
GDFLGDESLQEEEKD	OTOF	131	Q9HC10
ENQEEQGLEEKGEEF	FAM114A1	351	Q8IWE2
LVQLIEDYGEGDIEE	PURG	236	Q9UJV8
EINDDTLELEGGDEA	UPF2	526	Q9HAU5
LELEEEELGGEEEDT	IRX3	226	P78415
ELAYNEEEDGDGGEE	GOLM2	396	Q6P4E1
DGGEEDVQDDEEREL	GOLM2	406	Q6P4E1
DVGVEFEEDLRSVDG	RBP5	66	P82980
EEEEEAEGGRNSFEE	RSPH4A	511	Q5TD94
SEEGLEDAVEGADEA	TCP11L1	21	Q9NUJ3
LEELVFGDVENDEDA	UTP18	91	Q9Y5J1
GVTNEDLECLEEGEF	SENP7	761	Q9BQF6
IEEEANGDIFDIEIG	SNX2	131	O60749
EGDEEEEGHIVDAEA	POLR1A	1391	O95602
EAGGEEDVDDEVFEA	PSD	356	A5PKW4
QVGKEFEEDLTGIDD	RBP1	66	P09455
VVDRGTEFELDQDEG	RASGRP3	666	Q8IV61
IEEIDQGDLSGEEDQ	PNMA8B	206	Q9ULN7
DEEEGEEAELDGDLL	MEX3C	111	Q5U5Q3
DAGADELGEVIKDDI	SET	211	Q01105
DDLFQELDKNGDGEV	S100G	51	P29377
VEAQEEEEEQDHGVG	TAOK1	326	Q7L7X3
EDLGKDVEFEVVGDA	UBA2	536	Q9UBT2
VEEDEGLDDLENAEE	POLR2F	16	P61218
IGADEEELGSQIEEA	TCEA1	161	P23193
GEEEAGEDEADLLDT	RFXAP	81	O00287
LALDGETLGEEEQED	SCRIB	1416	Q14160
EGKLEGLTDEFEELE	ANP32D	31	O95626
GGSLEDEFDLELIEE	ASPRV1	316	Q53RT3
IDEADRDGDGEVNEE	CETN1	146	Q12798
LLGLGEETNEEDEEE	CEP164	211	Q9UPV0
EEEGEDDDLQGVGEE	CLMN	671	Q96JQ2
LAGELAGQEEEEALE	CHPF2	686	Q9P2E5
EEEEEEGEAAGENIG	CNKSR2	881	Q8WXI2
EKEAIAEEIFQDGEG	SUPT6H	141	Q7KZ85
AEEIFQDGEGEEGQE	SUPT6H	146	Q7KZ85
EDGADEAEAEIIQLL	TTC19	86	Q6DKK2
AEEEEEEDNLAAGVD	TMX4	276	Q9H1E5
LEDGEIDDAGFEEIQ	ZC3H6	16	P61129
EELEEIEEDAGLGNG	PYGM	121	P11217
ADLEEGEPAEGEQEL	SSH2	836	Q76I76
EGEGLQEEAVQLEET	RP1L1	1311	Q8IWN7
GEGQQEEEAQLEEIE	RP1L1	1346	Q8IWN7
EEEAQLEEIEETGGE	RP1L1	1351	Q8IWN7
LEEIEETGGEGLQEE	RP1L1	1356	Q8IWN7
DDGDEVFVEAESEGI	TPR	2261	P12270
EGGEDEIQFLRTEDE	RYR3	6	Q15413
DLVLDSDEEENGQGE	TINF2	391	Q9BSI4
EALEAGEVELSEGED	TONSL	481	Q96HA7
EELEEIEEDAGLGNG	PYGB	121	P11216
QEEDEEEGGGDVDIS	UNC119B	121	A6NIH7
ELGIELFEENEEEDE	ZHX1	826	Q9UKY1
TGGGFILEEEEEEEQ	XPA	71	P23025
EVGEADGEAEAAAEE	ZNF316	541	A6NFI3
EDEELENEACAVLGG	UBR7	26	Q8N806
EEEEDAAVGEQEGAR	VSIG10	471	Q8N0Z9
ETQDEDDDELIFVGE	ZNF280C	36	Q8ND82
ENEVGEADEELVDDG	ZBTB10	836	Q96DT7
DFDGEESGCEEELVQ	USP34	791	Q70CQ2
LGRQDGDEEFEEEEE	ZEB2	1151	O60315
DDIVDAGAIDDLEED	ZNF335	306	Q9H4Z2
EELEEIEEDAGLGNG	PYGL	121	P06737
QDEEEGLQSDGVIDD	VIRMA	741	Q69YN4
TVDEVGEEEDGDNDL	ZNF638	1776	Q14966
GEEEDGDNDLKVELA	ZNF638	1781	Q14966
DSKIGFEIGIENEED	ZNF449	221	Q6P9G9
EVGLEDLAAEDDEGF	ZNF76	116	P36508
AAVFEEGGDVDDLLD	XRCC5	716	P13010
GLGVQGAEEEEEEEE	ZFTA	181	C9JLR9
FEEQEDEIIGFGQEL	TSHR	356	P16473
QGEENLFETGDDEVI	N4BP1	191	O75113
LEVLLEEEAAGGDED	MYO9B	1946	Q13459
RNGLAEGTEQEEEEE	NAA30	166	Q147X3